Literature DB >> 9078236

Regulatory mechanisms that modulate signalling by G-protein-coupled receptors.

S K Böhm1, E F Grady, N W Bunnett.   

Abstract

The large and functionally diverse group of G-protein-coupled receptors includes receptors for many different signalling molecules, including peptide and non-peptide hormones and neuro-transmitters, chemokines, prostanoids and proteinases. Their principal function is to transmit information about the extracellular environment to the interior of the cell by interacting with the heterotrimeric G-proteins, and they thereby participate in many aspects of regulation. Cellular responses to agonists of these receptors are usually rapidly attenuated. Mechanisms of signal attenuation include removal of agonists from the extracellular fluid, receptor desensitization, endocytosis and down-regulation. Agonists are removed by dilution, uptake by transporters and enzymic degradation. Receptor desensitization is mediated by receptor phosphorylation by G-protein receptor kinases and second-messenger kinases, interaction of phosphorylated receptors with arrestins and receptor uncoupling from G-proteins. Agonist-induced receptor endocytosis also contributes to desensitization by depleting the cell surface of high-affinity receptors, and recycling of internalized receptors contributes to resensitization of cellular responses. Receptor down-regulation is a form of desensitization that occurs during continuous, long-term exposure of cells to receptor agonists. Down-regulation, which may occur during the development of drug tolerance, is characterized by depletion of the cellular receptor content, and is probably mediated by alterations in the rates of receptor degradation and synthesis. These regulatory mechanisms are important, as they govern the ability of cells to respond to agonists. A greater understanding of the mechanisms that modulate signalling may lead to the development of new therapies and may help to explain the mechanism of drug tolerance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9078236      PMCID: PMC1218151          DOI: 10.1042/bj3220001

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  228 in total

1.  Effect of peptidase inhibition on the pattern of intraspinally released immunoreactive substance P detected with antibody microprobes.

Authors:  A W Duggan; H G Schaible; P J Hope; C W Lang
Journal:  Brain Res       Date:  1992-05-08       Impact factor: 3.252

2.  Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors.

Authors:  J A Pitcher; J Inglese; J B Higgins; J L Arriza; P J Casey; C Kim; J L Benovic; M M Kwatra; M G Caron; R J Lefkowitz
Journal:  Science       Date:  1992-08-28       Impact factor: 47.728

3.  Relationship between agonist-induced muscarinic receptor loss and desensitization of stimulated phosphoinositide turnover in two neuroblastomas: methodological considerations.

Authors:  A K Thompson; S K Fisher
Journal:  J Pharmacol Exp Ther       Date:  1990-02       Impact factor: 4.030

4.  Molecular cloning and amino acid sequence of rat enkephalinase.

Authors:  B Malfroy; P R Schofield; W J Kuang; P H Seeburg; A J Mason; W J Henzel
Journal:  Biochem Biophys Res Commun       Date:  1987-04-14       Impact factor: 3.575

5.  Identification of a novel sequence mediating regulated endocytosis of the G protein-coupled alpha-pheromone receptor in yeast.

Authors:  J Rohrer; H Bénédetti; B Zanolari; H Riezman
Journal:  Mol Biol Cell       Date:  1993-05       Impact factor: 4.138

6.  Purification of endopeptidase-24.11 ('enkephalinase') from pig brain by immunoadsorbent chromatography.

Authors:  J M Relton; N S Gee; R Matsas; A J Turner; A J Kenny
Journal:  Biochem J       Date:  1983-12-01       Impact factor: 3.857

7.  Identification, purification, and characterization of GRK5, a member of the family of G protein-coupled receptor kinases.

Authors:  R T Premont; W J Koch; J Inglese; R J Lefkowitz
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

Review 8.  Lipid modifications of trimeric G proteins.

Authors:  P B Wedegaertner; P T Wilson; H R Bourne
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

9.  The conserved seven-transmembrane sequence NP(X)2,3Y of the G-protein-coupled receptor superfamily regulates multiple properties of the beta 2-adrenergic receptor.

Authors:  L S Barak; L Ménard; S S Ferguson; A M Colapietro; M G Caron
Journal:  Biochemistry       Date:  1995-11-28       Impact factor: 3.162

10.  Two isoforms of G protein-coupled receptor kinase 4 identified by molecular cloning.

Authors:  M Sallese; M S Lombardi; A De Blasi
Journal:  Biochem Biophys Res Commun       Date:  1994-03-15       Impact factor: 3.575

View more
  68 in total

1.  Kinetic analysis of the internalization and recycling of [3H]TRH and C-terminal truncations of the long isoform of the rat thyrotropin-releasing hormone receptor-1.

Authors:  T Drmota; G Milligan
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

2.  Ligand internalization and recycling by human recombinant somatostatin type 4 (h sst(4)) receptors expressed in CHO-K1 cells.

Authors:  K S Smalley; J A Koenig; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

3.  Activation and internalization of the mu-opioid receptor by the newly discovered endogenous agonists, endomorphin-1 and endomorphin-2.

Authors:  K McConalogue; E F Grady; J Minnis; B Balestra; M Tonini; N C Brecha; N W Bunnett; C Sternini
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

4.  RGS18 is a myeloerythroid lineage-specific regulator of G-protein-signalling molecule highly expressed in megakaryocytes.

Authors:  D Yowe; N Weich; M Prabhudas; L Poisson; P Errada; R Kapeller; K Yu; L Faron; M Shen; J Cleary; T M Wilkie; C Gutierrez-Ramos; M R Hodge
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

5.  A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation.

Authors:  M L Trincavelli; D Tuscano; M Marroni; A Falleni; V Gremigni; S Ceruti; M P Abbracchio; K A Jacobson; F Cattabeni; C Martini
Journal:  Mol Pharmacol       Date:  2002-12       Impact factor: 4.436

6.  Desensitisation of protease-activated receptor-1 (PAR-1) in rat astrocytes: evidence for a novel mechanism for terminating Ca2+ signalling evoked by the tethered ligand.

Authors:  J J Ubl; M Sergeeva; G Reiser
Journal:  J Physiol       Date:  2000-06-01       Impact factor: 5.182

7.  Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells.

Authors:  Leng Hong Pheng; Yvan Dumont; Alain Fournier; Jean-Guy Chabot; Alain Beaudet; Rémi Quirion
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

8.  Trafficking coordinate description of intracellular transport control of signaling networks.

Authors:  Jose M G Vilar; Leonor Saiz
Journal:  Biophys J       Date:  2011-11-15       Impact factor: 4.033

Review 9.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

Authors:  Laura N Vandenberg; Theo Colborn; Tyrone B Hayes; Jerrold J Heindel; David R Jacobs; Duk-Hee Lee; Toshi Shioda; Ana M Soto; Frederick S vom Saal; Wade V Welshons; R Thomas Zoeller; John Peterson Myers
Journal:  Endocr Rev       Date:  2012-03-14       Impact factor: 19.871

10.  Cross-desensitization of CCR1, but not CCR2, following activation of the formyl peptide receptor FPR1.

Authors:  Filip Bednar; Changcheng Song; Giuseppe Bardi; William Cornwell; Thomas J Rogers
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.